MedTrace Logo

A First Time in Human Study of PIN201104 in Healthy Volunteers and Patients With Asthma

NCT03058458 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2018-01-25

No results posted yet for this study

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of different single and repeat doses of PIN201104 in healthy volunteers and in patients with asthma.

Conditions

Interventions

DRUG

PIN201104

IV or SC administration

DRUG

Placebo

IV or SC administration

Sponsors & Collaborators

  • Peptinnovate

    lead INDUSTRY

Principal Investigators

  • Muna Albayaty, MBChB · Parexel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03058458 on ClinicalTrials.gov